New anti-counterfeiting group to target public health, not trade
This article was originally published in Clinica
Executive Summary
The World Health Organization (WHO) is to convene an intergovernmental working group on counterfeit medical products to examine public health – though not trade or IP-related – concerns. The measure was proposed by a WHO working group and approved by the World Health Assembly, on 21 May.